MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 109 filers reported holding MYOVANT SCIENCES LTD in Q4 2020. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $487,005 | -56.8% | 18,064 | -71.2% | 0.00% | – |
| Q3 2022 | $1,127,000 | +104.5% | 62,764 | +41.6% | 0.00% | – |
| Q2 2022 | $551,000 | -69.5% | 44,321 | -67.3% | 0.00% | – |
| Q1 2022 | $1,807,000 | -4.4% | 135,597 | +11.6% | 0.00% | – |
| Q4 2021 | $1,891,000 | -8.2% | 121,473 | +32.3% | 0.00% | – |
| Q3 2021 | $2,060,000 | -58.9% | 91,782 | -58.3% | 0.00% | -100.0% |
| Q2 2021 | $5,017,000 | +48.1% | 220,293 | +33.8% | 0.00% | 0.0% |
| Q1 2021 | $3,388,000 | -38.6% | 164,655 | -17.6% | 0.00% | -33.3% |
| Q4 2020 | $5,517,000 | +50.8% | 199,740 | -23.3% | 0.00% | +50.0% |
| Q3 2020 | $3,659,000 | +67.8% | 260,423 | +146.1% | 0.00% | +100.0% |
| Q2 2020 | $2,181,000 | +483.2% | 105,800 | +338.2% | 0.00% | 0.0% |
| Q4 2019 | $374,000 | – | 24,145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 85,000 | $1,132,000 | 1.20% |
| Bellevue Group AG | 5,859,039 | $78,042,000 | 0.91% |
| APIS CAPITAL ADVISORS, LLC | 40,000 | $533,000 | 0.64% |
| Pier Capital, LLC | 294,954 | $3,929,000 | 0.50% |
| Resolute Capital Asset Partners LLC | 50,000 | $666,000 | 0.42% |
| Rhenman & Partners Asset Management AB | 249,300 | $3,321,000 | 0.33% |
| Hennion & Walsh Asset Management, Inc. | 409,079 | $5,449,000 | 0.29% |
| TORRAY INVESTMENT PARTNERS LLC | 79,868 | $1,064,000 | 0.17% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 195,211 | $2,600,000 | 0.08% |
| DUALITY ADVISERS, LP | 54,164 | $721,000 | 0.08% |